Manufacturing

As patient-centered therapies and clinical trials become more important, innovation is providing more control and transparency in the way that pharmaceuticals are delivered.

Fujifilm has bought Biogen ApS’ Copenhagen facility for US$890 million.

Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.

Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.

Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.

Researchers in China are playing a role in advancing gene therapy development.

NIIMBL announced it is partnering with FDA through the University of Delaware to improve biopharmaceutical manufacturing.

Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.

Olon began construction of a GMP facility for biologic APIs in Capua, Italy.

Cytena Bioprocess Solutions, a new Cytena subsidiary in Taiwan, will provide bioprocess solutions for pharmaceutical companies and research institutes.

The first generics of Lyrica have been approved by the FDA for neuropathic pain management and adjunctive therapy.

The freedom of design found in additive manufacturing offers the potential for improved processing equipment, both in prototypes and commercial equipment.

Teva harmonizes its generic drug packaging brands under its corporate umbrella with a redesign.

The Coalition for Epidemic Preparedness Innovations is partnering with Colorado State University to develop a single-dose vaccine candidate against Rift Valley Fever.

Development and manufacturing machine specialists, groninger, have opened a new showroom at its headquarters based in Crailsheim, Germany.

Catalent Biologics has entered into a long-term strategic agreement to develop and manufacture an AveXis gene therapy treatment for spinal muscular atrophy (SMA), Zolgensma. 

Lonza plans to implement MES software to accelerate paperless, 24/7 production of drug capsules.

Process Automation Solutions becomes the latest partner to join the TrendMiner ecosystem.

Sartorius Stedim Biotech has unveiled a new single-use vessel for its ambr 250 modular benchtop automated mini bioreactor system that has been specifically designed for therapeutic cell lines.

The Bosch packaging machinery business, including the pharma unit, will remain intact in the transfer to private equity firm CVC.

Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.

Rockwell Automation’s updated FactoryTalk AssetCentre software supports several new types of production assets.

Recent studies show that more companies are evaluating or using AI, and that top-down management support is a driving force.

An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.

A new starch manufacturing plant near Amsterdam, The Netherlands will give Colorcon customers a second source of supply.